SFG
NWBO

Strive Financial Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Strive Financial Group’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19 Buy
+100
New +$19 ﹤0.01% 874

Other funds holding NWBO

KFA
Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

Strive Financial Group's NWBO Position: Q2 2026 in Review

Strive Financial Group opened a new position in Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2026: 100 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #874 among its holdings.

6 funds tracked by Wall St. Rank hold NWBO as of Q2 2026.

  • Strive Financial Group held 100 shares of Northwest Biotherapeutics, Inc. Common stock worth $19 as of Q2 2026.
  • Northwest Biotherapeutics, Inc. Common stock was a new Strive Financial Group position in Q2 2026.
  • Northwest Biotherapeutics, Inc. Common stock made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #874 holding.
  • 6 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.